Clindamycin Hydrochloride
Product Images NDC 67296-1315

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 67296-1315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clindamycin 150mg (Doc20170519134008 001)

Clindamycin 150mg (Doc20170519134008 001)
This is a description of two medications with the same active ingredient, Clindamycin HCL in capsule form with 150 mg concentration. The first medication is sold in a package of 40 capsules under the NDC 67296-1315-4, manufactured by G & W Laboratories Inc, and distributed by Redpharm Drug. The second medication has 60 capsules and is sold under NDC 67296-1315-6, with the same manufacturing and distribution information as the first one. Both medications are only for prescription use, and the adult dosage is explained in the package insert. The expiration date for both lots is 12/17, and it is recommended to store them at 20-25 C (68-77 F). The rest of the text contains codes and serial numbers, so it is not useful information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.